OncoArendi Therapeutics presents new AMCase and CHIT1 dual inhibitors for lung diseases Sep. 6, 2018 No Comments
Kalydeco approved in U.S. for cystic fibrosis in patients aged 12 to < 24 months Aug. 16, 2018 No Comments
RSS